Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr;46(2):114-120.
doi: 10.1159/000496751. Epub 2019 Feb 15.

Implementation of Molecular RHD Typing at Two Blood Transfusion Institutes from Southeastern Europe

Affiliations

Implementation of Molecular RHD Typing at Two Blood Transfusion Institutes from Southeastern Europe

Gordana Guzijan et al. Transfus Med Hemother. 2019 Apr.

Abstract

Introduction: Determination of RhD variants in blood donors, pregnant women, and newborns is important for transfusion strategies, in order to prevent RhD alloimmunisation and hemolytic disease of fetuses and newborns. Implementation of molecular RHD typing in two transfusion institutes is presented in this article, from Banja Luka (Bosnia and Herzegovina) and Belgrade (Serbia).

Study design and methods: Blood donors' RhD was checked by direct agglutination assays (tube) and indirect antiglobulin test (gel). Molecular RHD typing was performed by PCR-SSP with fluorometric signal detection in both centres. Donors were selected by weak RhD serological reactivity (Banja Luka, 85 samples; Belgrade, 62 samples) or serologically RhD-negative C/E-positive results (Banja Luka, 92 samples; Belgrade, 61 samples).

Results: Among serologically determined weak D donors from the institute from Banja Luka, weak D type 3 was the most frequent (58.8%), followed by type 1 (35.3%) and DNB (1.2%), whereas results obtained at the Belgrade institute were distributed between weak D type 1 (41.9%), type 3 (30.7%), type 14 (6.5%), type 15 (1.6%), and DNB with anti-D (1.6%). In 17.7% of serologically typed weak D samples from the Belgrade institute, the molecular typing result was standard D. Additionally, RHD presence was detected in 9.8% of serologically RhD-negative, C/E-positive samples from both institutes.

Conclusion: Rh molecular testing was successfully implemented in both blood transfusion institutes in Banja Luka and Belgrade. This study proved the efficiency of serological algorithms for weak D, as well as the presence of the RHD gene among serologically tested RhD-negative, C/E-positive samples.

Keywords: Molecular blood group typing; PCR; RHD gene; RHD variants; Rh phenotyping.

PubMed Disclaimer

Similar articles

Cited by

References

    1. International Society of Blood Transfusion Table of blood group antigens v8_180620, 2018. [accessed October 20, 2018], available from: http://www.isbtweb.org/fileadmin/user_upload/Red_Cell_Terminology_and_Im....
    1. Okuda H, Suganuma H, Kamesaki T, Kumada M, Tsudo N, Omi T, et al. The analysis of nucleotide substitutions, gaps, and recombination events between RHD and RHCE genes through complete sequencing. Biochem Biophys Res Commun. 2000 Aug;274((3)):670–83. - PubMed
    1. Daniels G. Variants of RhD—current testing and clinical consequences. Br J Haematol. 2013 May;161((4)):461–70. - PubMed
    1. Wagner FF, Flegel WA. RHD gene deletion occurred in the Rhesus box. Blood. 2000 Jun;95((12)):3662–8. - PubMed
    1. Avent ND, Ridgwell K, Tanner MJ, Anstee DJ. cDNA cloning of a 30 kDa erythrocyte membrane protein associated with Rh (Rhesus)-blood-group-antigen expression. Biochem J. 1990 Nov;271((3)):821–5. - PMC - PubMed